Multidrug resistance‐1 (MDR‐1): a new target for T cell‐based immunotherapy-Reference-Cited by-同舟云学术

Multidrug resistance‐1 (MDR‐1): a new target for T cell‐based immunotherapy

Published:2004-10-21 Issue:1 Volume:19 Page:158-159
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Niethammer Andreas G.¹,Wodrich Harald²,Loeffler Markus³,Lode Holger N.⁴,Emmerich Kathrin⁵,Abdollahi Amir¹,Krempien Robert¹,Debus Juergen¹,Huber Peter E.¹,Reisfeld Ralph A.³

Affiliation:

1. Department of Radiation OncologyHeidelberg Medical SchoolINF 40069120HeidelbergGermany

2. The Scripps Research InstituteDepartment of Cell BiologyLa JollaCaliforniaUSA

3. The Scripps Research InstituteDepartment of ImmunologyLa JollaCaliforniaUSA

4. Charité Children's HospitalDepartment of Pediatric OncologyBerlinGermany

5. Schering AGMüllerstrasse 17813342BerlinGermany

Funder

National Institutes of Health

U.S. Department of Defense

Tobacco-Related Disease Research Program

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.04-2355fje

Reference31 articles.

1. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma;Muul L. M.;J. Immunol,1987

2. Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapies;Itoh K.;In Viv,1991

3. Progress in human tumour immunology and immunotherapy

4. Progress in the development of immunotherapy for the treatment of patients with cancer

5. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA- transgenic mice;Xiang R.;Clin. Cancer. Res,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy;Frontiers in Immunology;2017-07-06

2. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer;International Immunopharmacology;2017-05

3. Reversal effect and mechanism of Ginkgo biloba exocarp extracts in multidrug resistance of mice S180 tumor cells;Experimental and Therapeutic Medicine;2016-08-11

4. Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects;Journal of Immunology Research;2016

5. Cytokine-induced killer (CIK) cells: from basic research to clinical translation;Chinese Journal of Cancer;2015-03-05